Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| C4 Therapeutics, Inc. | 1,083,991 | reported | 15 Feb 2026 | tx 33+4,709,897−148,566 |
| Editas Medicine, Inc. | 37,500 | reported | 06 Jun 2025 | tx 9+181,728 |
| BIND Therapeutics, Inc | 20,000 | reported | 22 Jun 2015 | tx 3+205,000 |
| AGIOS PHARMACEUTICALS, INC. | 11,785 | reported | 22 Apr 2020 | tx 28+388,641−45,957 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Feb 2026 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 39,154 | 1.89 USD | |
| 13 Feb 2026 | GRANT_AWARD | C4 Therapeutics, Inc. | 700,000 | 0.00 USD | |
| 14 Feb 2026 | EXERCISE | C4 Therapeutics, Inc. | 81,725 | 0.00 USD | |
| 15 Feb 2026 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 9,057 | 1.89 USD | |
| 15 Feb 2026 | EXERCISE | C4 Therapeutics, Inc. | 20,400 | 0.00 USD | |
| 06 Jun 2025 | GRANT_AWARD | Editas Medicine, Inc. | 37,500 | 0.00 USD | deriv |
| 14 Feb 2025 | GRANT_AWARD | C4 Therapeutics, Inc. | 223,500 | 0.00 USD | |
| 15 Feb 2025 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 9,370 | 3.18 USD | |
| 14 Feb 2025 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 12,847 | 3.18 USD | |
| 14 Feb 2025 | GRANT_AWARD | C4 Therapeutics, Inc. | 335,300 | 0.00 USD | deriv |
| 07 Nov 2024 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 5,550 | 6.04 USD | |
| 07 Nov 2024 | EXERCISE | C4 Therapeutics, Inc. | 12,500 | — | |
| 07 Nov 2024 | EXERCISE | C4 Therapeutics, Inc. | 12,500 | 0.00 USD | deriv |
| 16 Sept 2024 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 3,329 | 6.36 USD | |
| 16 Sept 2024 | EXERCISE | C4 Therapeutics, Inc. | 7,500 | — | |
| 16 Sept 2024 | EXERCISE | C4 Therapeutics, Inc. | 7,500 | 0.00 USD | deriv |
| 30 May 2024 | GRANT_AWARD | Editas Medicine, Inc. | 25,000 | 0.00 USD | deriv |
| 14 Feb 2024 | GRANT_AWARD | C4 Therapeutics, Inc. | 103,400 | 0.00 USD | |
| 14 Feb 2024 | GRANT_AWARD | C4 Therapeutics, Inc. | 465,500 | 0.00 USD | deriv |
| 15 Feb 2024 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 6,560 | 7.90 USD | |
| 18 Sept 2023 | GRANT_AWARD | C4 Therapeutics, Inc. | 489,600 | 0.00 USD | deriv |
| 30 Aug 2023 | EXERCISE | C4 Therapeutics, Inc. | 7,500 | — | |
| 30 Aug 2023 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 2,205 | 2.93 USD | |
| 30 Aug 2023 | EXERCISE | C4 Therapeutics, Inc. | 7,500 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | Editas Medicine, Inc. | 25,000 | 0.00 USD | deriv |